Subscribe

James E. Wagner Cultivation Corporation (JWCAF)

USD0.00 +0.00 (+0.00%)
CA OTC Healthcare Drug Manufacturers - Specialty & Generic
Address 530 Trillium Drive N2R 1J4
Kitchener, ON, CA
CEO Nathaniel Woodworth
Website jwc.ca
IPO 2018-06-25
ISIN CA47031P1080

Explore sections of this company profile

Description

James E. Wagner Cultivation Corporation, operating primarily through its subsidiary, James E. Wagner Cultivation Ltd., is a Canadian enterprise focused on the growth and supply of cannabis for medical purposes. The company distinguishes itself by committing to the production of pure and uniform cannabis products, leveraging its exclusive aeroponic cultivation technology, dubbed GrowthSTORM. This firm was established in 2007 and has its main operational base in Kitchener, Canada.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD0.00 +0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
4.1K
Beta
0.63
Float Shares
101.73M
Free Float %
93.0%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.00% +0.00% +0.00% +0.00% +0.00% +0.00% +0.00% +900.00% -99.67% -99.99% -99.99%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
0.00
Ratings Trend (MoM)
Rating 2024-11 Change
Strong Buy 0 0
Buy 0 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
-1.22
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
0 / 10
No MOAT
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%
    +3,598.7% ★ Q4'19: -57.0% (vs Q4'18)
  • ✗
    EPS growth Drug Manufacturers - Specialty & Generic: +16.5%
    +48.1% ★ Q4'19: +66.7% (vs Q4'18)
  • ✗
    FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%
    -386.2% Q4'19: -1,489.9% (vs Q4'18)
  • ✗
    EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%
    -404.1% Q4'19: -255.4% (vs Q4'18)
  • ✗
    ROIC Drug Manufacturers - Specialty & Generic: +6.5%
    -55.1% Q4'19: -6.9% (vs Q4'18)
  • ✗
    Share dilution Drug Manufacturers - Specialty & Generic: +0.0%
    +30.7% Q4'19: +50.5% (vs Q4'18)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×
    -0.72× Q4'19: 38.18× (vs Q4'18)
Valuation Multiples From To
DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.63) × ERP
WACC = 0% × Ke + 100% × Kd (9.3%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Current price: 0.00
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Sep 2018
actual 		Sep 2019
actual 		Sep 2020
actual 		Sep 2021
actual 		Sep 2024
actual 		Sep 2025
actual 		Sep 2026
1 Rev. Ana.
1 EPS Ana. 		Sep 2027
1 Rev. Ana.
1 EPS Ana. 		Sep 2028
1 Rev. Ana.
1 EPS Ana. 		Sep 2029
1 Rev. Ana.
1 EPS Ana.
Revenue
57.6K
est: 2.01M (-97.1%)
2.13M
est: 4.92M (-56.7%)
12.75M
est.
40.15M
est.
2.09M
est.
2.16M
est.
2.15M
2.15M – 2.15M
-0.3% YoY
5.14M
5.14M – 5.14M
+139.2% YoY
13.32M
13.32M – 13.32M
+158.9% YoY
44.04M
44.04M – 44.04M
+230.7% YoY
EBITDA
-6.85M
est: -2.01M (-241.4%)
-7.28M
est: -4.92M (-47.9%)
-12.75M
est.
-40.15M
est.
-2.09M
est.
-2.16M
est.
-2.15M
-2.15M – -2.15M
+0.3% YoY
-5.14M
-5.14M – -5.14M
-139.2% YoY
-13.32M
-13.32M – -13.32M
-158.9% YoY
-44.04M
-44.04M – -44.04M
-230.7% YoY
EBIT
-7.21M
est: -2.01M (-259.5%)
-8.61M
est: -4.92M (-74.9%)
-12.75M
est.
-40.15M
est.
-2.09M
est.
-2.16M
est.
-2.15M
-2.15M – -2.15M
+0.3% YoY
-5.14M
-5.14M – -5.14M
-139.2% YoY
-13.32M
-13.32M – -13.32M
-158.9% YoY
-44.04M
-44.04M – -44.04M
-230.7% YoY
Net Income
-10.31M
est: -6.76M (-52.6%)
-6.99M
est: -6.77M (-3.2%)
-3.84M
est.
4.81M
est.
-7.04M
est.
-7.27M
est.
-7.27M
-7.27M – -7.27M
+0.0% YoY
-7.10M
-7.10M – -7.10M
+2.4% YoY
-4.02M
-4.02M – -4.02M
+43.4% YoY
5.29M
5.29M – 5.29M
+231.6% YoY
SGA
7.83M
est: 139.67M (-94.4%)
7.33M
est: 342.94M (-97.9%)
888.05M
est.
2.80B
est.
145.57M
est.
150.30M
est.
149.78M
149.78M – 149.78M
-0.3% YoY
358.27M
358.27M – 358.27M
+139.2% YoY
927.65M
927.65M – 927.65M
+158.9% YoY
3.07B
3.07B – 3.07B
+230.7% YoY
EPS
-0.14
est: -0.07 (-99.5%)
-0.08
est: -0.07 (-7.3%)
-0.04
est.
0.05
est.
-0.07
est.
-0.08
est.
-0.08
-0.08 – -0.08
+0.0% YoY
-0.07
-0.07 – -0.07
+2.4% YoY
-0.04
-0.04 – -0.04
+43.4% YoY
0.05
0.05 – 0.05
+231.6% YoY

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-9.84M
OE per share TTM
-0.10
Owner's Yield
-84,320.25%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
897.0%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
-538.00
Shares Outstanding
109.42M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Nathaniel Woodworth President & Chief Executive Officer 152.4K male
James den Ouden Chief Financial Officer 127.0K male
Adam Woodworth Chief Operating Officer, QA Supervisor & Chief Cultivator 101.6K male
Krysta Woodworth Chief Administrative Officer 101.6K female
Laura Emma-Elizabeth Foster Chief Compliance Officer & Director 87.1K female
William Werth Chief Technology Officer — male
Daniel Bexon Chief Information Officer — male
Eric Kraushaar General Counsel — —
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Drug Manufacturers - Specialty & Generic